Page last updated: 2024-09-05

5-bromowillardiine and Cerebral Palsy, Athetoid

5-bromowillardiine has been researched along with Cerebral Palsy, Athetoid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arzimanoglou, A; Baud, O; Gressens, P; Sfaello, I	1

Other Studies

1 other study(ies) available for 5-bromowillardiine and Cerebral Palsy, Athetoid

Article	Year
Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiology of disease, 2005, Volume: 20, Issue:3 Topics: Alanine; Animals; Animals, Newborn; Brain; Cerebral Palsy; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Fructose; Glutamic Acid; Humans; Hypoxia, Brain; Ibotenic Acid; Infant, Newborn; Leukomalacia, Periventricular; Male; Mice; Neuroprotective Agents; Neurotoxins; Rats; Rats, Sprague-Dawley; Topiramate; Treatment Outcome	2005

Article

Year

Topiramate prevents excitotoxic damage in the newborn rodent brain.

Neurobiology of disease, 2005, Volume: 20, Issue:3

Topics: Alanine; Animals; Animals, Newborn; Brain; Cerebral Palsy; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Fructose; Glutamic Acid; Humans; Hypoxia, Brain; Ibotenic Acid; Infant, Newborn; Leukomalacia, Periventricular; Male; Mice; Neuroprotective Agents; Neurotoxins; Rats; Rats, Sprague-Dawley; Topiramate; Treatment Outcome

2005